Recording of HIV viral loads and viral suppression in South African patients receiving antiretroviral treatment: a multicentre cohort study

T Pillay, M Cornell, MP Fox, J Euvrard, G Fatti… - Antiviral …, 2020 - journals.sagepub.com
Background Viral suppression in patients on antiretroviral treatment (ART) is critical to
reducing HIV transmission and HIV-related mortality. Although many studies have evaluated …

How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in …

J Euvrard, T Schulz, K Hilderbrand… - South African Medical …, 2019 - journals.co.za
Background. The Joint United Nations Programme on HIV/AIDS (UNAIDS) third 90-90-90
target requires 90% of patients on antiretroviral treatment (ART) to be virally suppressed (< 1 …

Virological suppression and clinical management in response to viremia in South African HIV treatment program: a multicenter cohort study

LE Hermans, S Carmona, M Nijhuis… - PLoS …, 2020 - journals.plos.org
Background Uptake of antiretroviral treatment (ART) is expanding rapidly in low-and middle-
income countries (LMIC). Monitoring of virological suppression is recommended at 6 months …

Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional …

WM Han, MG Law, M Egger, K Wools-Kaloustian… - The lancet HIV, 2021 - thelancet.com
Background As countries move towards the UNAIDS's 95-95-95 targets and with strong
evidence that undetectable equals untransmittable, it is increasingly important to assess …

Determinants of viral load non-suppression among people living with HIV on antiretroviral therapy in Kumasi, Ghana

D Ansah, E Kumah, V Bawontuo, P Agyei-Baffour… - Ghana Medical …, 2021 - ajol.info
Objectives: To determine the rate and factors associated with viral load non-suppression
among adults living with HIV/AIDS on active anti-retroviral therapy (ART). Design: A …

Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014–July 2015

L Bulage, I Ssewanyana, V Nankabirwa… - BMC infectious …, 2017 - Springer
Background Despite the growing number of people on antiretroviral therapy (ART), there is
limited information about virological non-suppression and its determinants among HIV …

Prevalence of nonsuppressed viral load and associated factors among HIV‐positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and …

AD Haas, E Radin, AJ Hakim, A Jahn… - Journal of the …, 2020 - Wiley Online Library
Introduction The global target for 2020 is that≥ 90% of people living with HIV (PLHIV)
receiving antiretroviral therapy (ART) will achieve viral load suppression (VLS). We …

Human Immunodeficiency Virus Viral Load Monitoring and Rate of Virologic Suppression Among Patients Receiving Antiretroviral Therapy in Democratic Republic of …

N Mayasi Ngongo, E Kamangu Ntambwe… - Open Forum …, 2023 - academic.oup.com
Background Antiretroviral therapy (ART) expansion and viral load as a treatment monitoring
approach have increased the demand for viral load testing. Many hurdles affect the …

Factors associated with viral load non-suppression in people living with HIV on ART in Nigeria: cross-sectional analysis from 2017 to 2021

S Tomescu, T Crompton, J Adebayo, F Akpan… - BMJ open, 2023 - bmjopen.bmj.com
Objectives Identify factors (demographic and clinical) associated with a non-suppressed
viral load (VL) of people living with HIV (PLHIV) on antiretroviral therapy (ART) in Nigeria …

HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two-year retrospective cohort study in Northern Tanzania

MS Kahabuka, Y Woldeamanuel, PM Mbelele… - BMC Infectious …, 2024 - Springer
Background The world is moving towards the third target of the Joint United Nations
Programme on HIV/AIDS to ensure most people receiving antiretroviral therapy (ART) are …